SCHEMBL32669043

SCHEMBL32669043

C=CCCCOCC(C)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.50
PLA2G2C Q5R387 1/20 0.39
TDP1 Q9NUW8 1/20 0.38
USP2 O75604 3/20 0.37
CYP3A4 P08684 2/20 0.37
MAPT P10636 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 2/20 0.37
RECQL P46063 1/20 0.37
ALDH1A1 P00352 4/20 0.36
TSHR P16473 3/20 0.36
HPGD P15428 1/20 0.36
LPAR3 Q9UBY5 2/20 0.33
SPHK1 Q9NYA1 1/20 0.33
LPAR2 Q9HBW0 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 1/20 0.32
MAPK1 P28482 1/20 0.32
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669046 0.92 HSD17B10 (0.47) HSD17B10PLA2G2CTDP1USP2CYP3A4
SCHEMBL32669042 0.87
SCHEMBL16026686 0.83 CA1 (0.42) HSD17B10PLA2G2CUSP2CYP3A4MAPT
SCHEMBL5735012 0.83 TSHR (0.39) PLA2G2CTDP1USP2CYP3A4MAPT
SCHEMBL10489648 0.82 HSD17B10 (0.48) HSD17B10PLA2G2CTDP1USP2LMNA
SCHEMBL29467780 0.80 HSD17B10 (0.47) HSD17B10PLA2G2CTDP1USP2LMNA
SCHEMBL29467781 0.80 HSD17B10 (0.47) HSD17B10PLA2G2CTDP1USP2LMNA
SCHEMBL29467783 0.80 HSD17B10 (0.47) HSD17B10PLA2G2CTDP1USP2LMNA
SCHEMBL23615870 0.79 HSD17B10 (0.39) HSD17B10PLA2G2CTDP1USP2CYP3A4
SCHEMBL13568045 0.79 HSD17B10 (0.67) HSD17B10TDP1USP2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS GOODYEAR TIRE & RUBBER (US) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035494-A1 METHOD FOR COLD FLOW REDUCTION OF ELASTOMERS ITGA1, HSPA1A, SHC1 HSD17B10 905/4885PLA2G2C 3688/4885TDP1 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.